Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]
Future OncolNavari RM +7 more
europepmc +1 more source
A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen. [PDF]
Int J Mol SciKast RE +2 more
europepmc +1 more source
Do Not Throw Away Your Patient's Shot at Complete Vomiting Control. [PDF]
J Pediatr Pharmacol TherDupuis LL, Patel P.
europepmc +1 more source
Evidence-Based Perioperative Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Laparoscopic Bariatric Surgery: A Scoping Review. [PDF]
J Clin MedMieszczański P +4 more
europepmc +1 more source
Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]
CureusSarma I +7 more
europepmc +1 more source
Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study. [PDF]
J Pharm Health Care SciOhtsubo T +15 more
europepmc +1 more source
Effect of Neurokinin-1 Receptor Antagonists on Experimental Postoperative Adhesion: A Systematic Review and Meta-Analysis with Trial Sequential Analysis of Preclinical Studies. [PDF]
Medicina (Kaunas)Hwang HJ +4 more
europepmc +1 more source
A Dual-Purpose Approach for an Anti-Emetic NK1R Antagonist as a Chemosensitizer and Cardioprotectant in a Preclinical Model of Triple-Negative Breast Cancer. [PDF]
Int J Mol SciMuñoz M +6 more
europepmc +1 more source
Cannabinoid Hyperemesis Syndrome Treated With Fosaprepitant: A Case Report. [PDF]
CureusMoore MD, Alzghari SK, Soliman AN.
europepmc +1 more source